Serum Institute of India to produce additional 100 million COVID-19 vaccine doses for India

The Serum Institute of India (SII) on Tuesday said it would produce upto an additional 100 million COVID-19 vaccine doses for India in 2021. Other than for India, the COVID-19 vaccines will also be produced for low and middle-income countries, the Serum Institute of India said. Further, the SII said the development takes forward the collaboration between SII, Gavi, Vaccine Alliance and Bill & Melinda Gates Foundation.

from IndiaTV India: Google News Feed https://ift.tt/30hDgS0
via